NCT01510145

Efficacy of Changing to TRAVATAN® From Prior Therapy

Multi-Center Study Comparing Efficacy and Tolerability of TRAVATAN® BAK-free (0.004% Travoprost) in Patients Previously on Latanoprost Ophthalmic Solution 0.005% Monotherapy

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 191 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to assess the efficacy and tolerability of TRAVATAN® solution without BAK (benzalkonium chloride) after changing from prior latanoprost 0.005% ophthalmic solution monotherapy in subjects with open-angle glaucoma or ocular hypertension due to tolerability issues.

Conditions

• Open-angle Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	Travoprost 0.004% BAK-free	Containing Polyquad (PQ) preservative

Timeline

• Start date: 2012-02-01
• Primary completion: 2013-05-01
• Completion: 2013-05-01
• First posted: 2012-01-13
• Last updated: 2014-06-13
• Results posted: 2014-06-13